Planes, trains and automobiles: Reducing the risks of traveling this summer

After enduring more than two months of quarantine, businesses and institutions are reopening, spurring summer travel plans to satisfy the urge to escape confinement. But is it safe to travel with the threat of COVID-19 still lingering? Experts at UT Physicians/UTHealth weigh in.

Read more

New chemotherapy drug studied for malignant brain tumor in children

MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in laboratory models of medulloblastoma, the most common malignant brain tumor in children. Now, MTX110 is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma.

Read more